Gout & crystal arthritis

Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat?

Rheumatology (Oxford)Published Prospective cohort study

Authors' conclusion

The 0.1 cm3 threshold was better correlated with clinical presentation and evolution than the 0.01 cm3 threshold. Gout patients with negative DECTs exhibit milder disease and a lower comorbidity burden. They do not exhibit particularly easy-to-treat hyperuricaemia but they may have a lower risk of flares.

Study context

Population
Gout patients naïve to urate-lowering therapy (ULT) with baseline dual-energy CT (DECT) scans of the knees and feet, CRYSTALILLE cohortmedian age 66.2 years
Participants
211 participants
Exposure
Negative vs positive DECT for MSU crystal deposition
  • <0.1 cm³n = 90
  • <0.01 cm³n = 38
Outcome
Flares after ULT initiation
Follow-up
6, 12 and 24 months
Methodological detailsCRYSTALILLE cohort, two DECT positivity thresholds (<0.01 cm³ and <0.1 cm³)
  • CRYSTALILLE cohort
  • Two DECT positivity thresholds (<0.01 cm³ and <0.1 cm³)

Main finding

As reported in the abstract

GroupValue12 months24 months
<0.1 cm³23.1%3/26 (11.5%)1/18 (5.6%)
≥0.1 cm³40.0%9/36 (25.0%)2/18 (11.1%)

Value

<0.1 cm³23.1%
≥0.1 cm³40.0%

12 months

<0.1 cm³3/26 (11.5%)
≥0.1 cm³9/36 (25.0%)

24 months

<0.1 cm³1/18 (5.6%)
≥0.1 cm³2/18 (11.1%)
  • <0.1 cm³ vs ≥0.1 cm³: P > 0.05

Observational data: associations, not effects.

Further findings

Outcome<0.1 cm³<0.01 cm³
Negative DECT prevalence · baseline43%18%

Negative DECT prevalence · baseline

Factors associated with negative DECT: younger age, shorter symptom duration, absence of CVD (both thresholds)

Serum urate (SU) target attainment (overall)

Reached SU <6.0 mg/dl
95 (68.3%)
Reached SU <5.0 mg/dl
68 (48.9%)
No difference between positive and negative DECTs; ULT doses tended to be lower with negative DECT

Original publication

Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat? Rheumatology (Oxford). Published 9 February 2024. doi:10.1093/rheumatology/keae061

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.